Targeting the metabolism of cancer stem cells by energy disruptor molecules. 2022

Tahere Dadgar, and Nasim Ebrahimi, and Amir Reza Gholipour, and Maryam Akbari, and Leila Khani, and Amirhossein Ahmadi, and Michael R Hamblin
Department of Biology, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran.

Cancer stem cells (CSCs) have been identified in various tumor types. CSCs are believed to contribute to tumor metastasis and resistance to conventional therapy. So targeting these cells could be an effective strategy to eliminate tumors and a promising new type of cancer treatment. Alterations in metabolism play an essential role in CSC biology and their resistance to treatment. The metabolic properties pathways in CSCs are different from normal cells, and to some extent, are different from regular tumor cells. Interestingly, CSCs can use other nutrients for their metabolism and growth. The different metabolism causes increased sensitivity of CSCs to agents that disrupt cellular homeostasis. Compounds that interfere with the central metabolic pathways are known as energy disruptors and can reduce CSC survival. This review highlights the differences between regular cancer cells and CSC metabolism and discusses the action mechanisms of energy disruptors at the cellular and molecular levels.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014411 Neoplastic Stem Cells Highly proliferative, self-renewing, and colony-forming stem cells which give rise to NEOPLASMS. Cancer Stem Cells,Colony-Forming Units, Neoplastic,Stem Cells, Neoplastic,Tumor Stem Cells,Neoplastic Colony-Forming Units,Tumor Initiating Cells,Cancer Stem Cell,Cell, Cancer Stem,Cell, Neoplastic Stem,Cell, Tumor Initiating,Cell, Tumor Stem,Cells, Cancer Stem,Cells, Neoplastic Stem,Cells, Tumor Initiating,Cells, Tumor Stem,Colony Forming Units, Neoplastic,Colony-Forming Unit, Neoplastic,Initiating Cell, Tumor,Initiating Cells, Tumor,Neoplastic Colony Forming Units,Neoplastic Colony-Forming Unit,Neoplastic Stem Cell,Stem Cell, Cancer,Stem Cell, Neoplastic,Stem Cell, Tumor,Stem Cells, Cancer,Stem Cells, Tumor,Tumor Initiating Cell,Tumor Stem Cell,Unit, Neoplastic Colony-Forming,Units, Neoplastic Colony-Forming
D053858 Metabolic Networks and Pathways Complex sets of enzymatic reactions connected to each other via their product and substrate metabolites. Metabolic Networks,Metabolic Pathways,Metabolic Network,Metabolic Pathway,Network, Metabolic,Networks, Metabolic,Pathway, Metabolic,Pathways, Metabolic

Related Publications

Tahere Dadgar, and Nasim Ebrahimi, and Amir Reza Gholipour, and Maryam Akbari, and Leila Khani, and Amirhossein Ahmadi, and Michael R Hamblin
January 2018, Methods in molecular biology (Clifton, N.J.),
Tahere Dadgar, and Nasim Ebrahimi, and Amir Reza Gholipour, and Maryam Akbari, and Leila Khani, and Amirhossein Ahmadi, and Michael R Hamblin
June 2020, World journal of stem cells,
Tahere Dadgar, and Nasim Ebrahimi, and Amir Reza Gholipour, and Maryam Akbari, and Leila Khani, and Amirhossein Ahmadi, and Michael R Hamblin
January 2018, Cancer management and research,
Tahere Dadgar, and Nasim Ebrahimi, and Amir Reza Gholipour, and Maryam Akbari, and Leila Khani, and Amirhossein Ahmadi, and Michael R Hamblin
July 2021, Phytotherapy research : PTR,
Tahere Dadgar, and Nasim Ebrahimi, and Amir Reza Gholipour, and Maryam Akbari, and Leila Khani, and Amirhossein Ahmadi, and Michael R Hamblin
January 2019, Frontiers in pharmacology,
Tahere Dadgar, and Nasim Ebrahimi, and Amir Reza Gholipour, and Maryam Akbari, and Leila Khani, and Amirhossein Ahmadi, and Michael R Hamblin
January 2009, Molecular nutrition & food research,
Tahere Dadgar, and Nasim Ebrahimi, and Amir Reza Gholipour, and Maryam Akbari, and Leila Khani, and Amirhossein Ahmadi, and Michael R Hamblin
February 2021, European journal of medicinal chemistry,
Tahere Dadgar, and Nasim Ebrahimi, and Amir Reza Gholipour, and Maryam Akbari, and Leila Khani, and Amirhossein Ahmadi, and Michael R Hamblin
March 2021, Cell stem cell,
Tahere Dadgar, and Nasim Ebrahimi, and Amir Reza Gholipour, and Maryam Akbari, and Leila Khani, and Amirhossein Ahmadi, and Michael R Hamblin
June 2023, Biochemical pharmacology,
Tahere Dadgar, and Nasim Ebrahimi, and Amir Reza Gholipour, and Maryam Akbari, and Leila Khani, and Amirhossein Ahmadi, and Michael R Hamblin
January 2015, International journal of nanomedicine,
Copied contents to your clipboard!